Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Dermatology partnering terms and agreements


Published on

  • Be the first to comment

  • Be the first to like this

Dermatology partnering terms and agreements

  1. 1. Dermatology Partnering Terms and Agreements The Dermatology Partnering Terms and Agreements report provides a detailed understanding and analysis ofhow and why companies enter dermatology partnering deals. The majority of deals are discovery, preclinicalor development stage whereby the licensee obtains a right or an option right to license the licensors bacterialstechnology. These deals tend to be multicomponent, starting with collaborative R&D, and commercializationof outcomes. This report provides details of the latest dermatology deals and contracts announced in the healthcare sectors. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insightinto the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilstmany smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms ofhow payments are triggered – contract documents provide this insight where press releases anddatabases do not. The report includes an analysis of financial deal terms by stage at signing covering headline value, upfrontpayment, milestone payments and royalty rates. The initial chapters of this report provide an orientation ofdermatology dealmaking and business activities. Chapter 1 provides an introduction to the report. Chapter 2 provides an overview of the trends in dermatology dealmaking since 2007 covering trends by year,deal type, stage of development, technology type and therapeutic indication. In addition the chapter includesan analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestonepayments and royalty rates. Analysis includes median values and distribution of values for each stage ofdevelopment. Chapter 3 provides a review of the leading dermatology deals since 2007. Deals are listed by headline value,signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal hasan agreement contract published at the SEC a link provides online access to the contract. Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summaryfollowed by a comprehensive listing of dermatology deals, as well as contract documents available in thepublic domain. Where available, each deal title links via Weblink to an online version of the actual contractdocument, providing easy access to each contract document on demand. Chapter 5 provides comprehensive access to all dermatology deals since 2007 where a deal contract isavailable, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Eachdeal title links via Weblink to an online version of the deal record contract document, providing easy access toeach contract document on demand. Chapter 6 provides a comprehensive directory of all dermatology partnering deals signed and announcedsince 2007. The chapter is organized by specific dermatology therapy focus. Each deal title links via Weblinkto an online version of the deal record and where available, the contract document, providing easy access toeach contract document on demand. In addition, a comprehensive appendix is provided with each report of all dermatology partnering deals signedand announced since 2007. The appendices are organized by company A-Z, stage of development at signing,deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links viaDermatology Partnering Terms and Agreements
  2. 2. Weblink to an online version of the deal record and where available, the contract document, providing easyaccess to each contract document on demand. The report also includes numerous tables and figures that illustrate the trends and activities in dermatologypartnering and dealmaking since 2007. In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in theresearch, development and commercialization of dermatology technologies and products. Key benefits Dermatology Partnering Terms and Agreementsprovides the reader with the following keybenefits: In-depth understanding of dental deal trends since 2007 Access dental deal headline, upfront, milestone androyalty data Research hundreds of actual contracts between dermatology partner companies Comprehensiveaccess to over 1500 links to actual dermatology deals entered into by the world’s biopharma companiesIndepth review of dental deals entered into by the leading fifty bigpharma companies Benchmark the key dealterms companies have agreed in previous deals Identify key terms under which companies partnerdermatology opportunities Uncover companies actively partnering dermatology opportunities Report scope Dermatology Partnering Terms and Agreements is intended to provide the reader with an in-depthunderstanding and access to dermatology trends and structure of deals entered into by leading companiesworldwide. Dermatology Partnering Terms and Agreements includes: Trends in dermatology dealmaking in the biopharma industry since 2007 Analysis of dermatology dealstructure Access to headline, upfront, milestone and royalty data Access to hundreds of dermatology dealcontract documents Comprehensive access to over 1500 dermatology deal records The leading dermatologydeals by value since 2007 Most active dermatology dealmakers since 2007 In Dermatology Partnering Terms and Agreements, available deals and contracts are listed by: Headline value o Upfront payment value Royalty rate value o Stage of development at signing Dealcomponent type Technology type Specific therapy indication Each deal title links via Weblink to an onlineversion of the deal record and where available, the contract document, providing easy access to each contractdocument on demand.table Of Contentsexecutive Summarychapter 1 – Introductionchapter 2 – Trends In Dermatology Dealmaking2.1. Introduction2.2. Dermatology Partnering Over The Years2.3. Bigpharma Dermatology Dealmaking Activity2.4. Bigpharma Not Active In Dermatology2.5. Dermatology Partnering By Deal TypeDermatology Partnering Terms and Agreements
  3. 3. 2.6. Dermatology Partnering By Industry Sector2.7. Dermatology Partnering By Stage Of Development2.8. Dermatology Partnering By Technology Type2.9. Dermatology Partnering By Dermatology Indication2.10. Average Deal Terms For Dermatology2.10.1 Dermatology Headline Values2.10.2 Dermatology Upfront Payments2.10.3 Dermatology Milestone Payments2.10.4 Dermatology Royalty Rateschapter 3 – Leading Dermatology Deals3.1. Introduction3.2. Top Dermatology Deals By Value3.3. Top Dermatology Deals Involving Bigpharmachapter 4 – Bigpharma Dermatology Deals4.1. Introduction4.2. How To Use Bigpharma Partnering Deals4.3. Bigpharma Dermatology Partnering Company Profilesabbottactavisactelionallerganamgenastellasastrazenecabaxter Internationalbayerbristol-myerssquibb Celgeneeli Lillyendo Pharmaceuticalsforest Laboratoriesgaldermaglaxosmithklinehospirajohnson & Johnsonmerck & Comerck Kgaamitsubishi TanabenovartispfizerDermatology Partnering Terms and Agreements
  4. 4. rochesanofishionogishiretevawarner Chilcottwatsonchapter 5 – Dermatology Partnering Contracts Directory5.1. Introduction5.2. By Deal Typeasset Purchaseassignmentbigpharma Outlicensingco-developmentcollaborative R&dco-marketcontract Serviceco-promotiondevelopmentdistributionequity Purchasejoint Venturelicensinglitigationloanmanufacturingmarketingoptionpromotionresearchsettlementsub-licensesupplytermination5.3. By Stage Of Developmentdiscoveryformulationmarketedphase Iphase Iiphase IiiDermatology Partnering Terms and Agreements
  5. 5. preclinical5.4. By Technology Typeantibodiesassaysbiologicalcompoundsbiomaterialsclinical Testingdevicesdiagnosticsdna Probesdrug Deliveryenabling Technologyequipmentgenomicsnatural Productoligonucleotideorphan Drugpeptidesprocessesrecombinant Dnaregenerative Medicineresearch Servicesresearch Suppliesscreeningsmall Moleculesstem Cellschapter 6 – Dermatology Dealmaking By Indication6.1. Introduction6.2. Deals By Therapeutic Indicationdermatologyacneactinickeratosisangioedemaburnscellulitiscosmeticsdermatitisdiabetic Foot Ulcereczema Hair Disordersimpetigoitchingnail DisordersDermatology Partnering Terms and Agreements
  6. 6. psoriasis Rosaceasun Damagerash Scarvenous Ulcerwound Healingwrinkleschapter 7 – Partnering Resource Center7.1. Online Partnering7.2. Partnering Events7.3. Further Reading On Dealmakingappendicesappendix 1 – Directory Of Dermatology Deals By Company A-z 2007-2012appendix 2 – Directory Of Dermatology Deals By Deal Type 2007-2012asset Purchaseassignmentbigpharma Outlicensingco-developmentcollaborative R&dco-marketcontract Serviceco-promotioncradacross-licensingdevelopmentdistributionequity Purchaseevaluationgrantjoint Venturelicensinglitigationloanmanufacturingmanufacturing - Oemmarketingmaterial Transferoptionpromotionresearchroyalty FinancingDermatology Partnering Terms and Agreements
  7. 7. settlementspin Outsub-licensesupplytechnology Transferterminationwarrantyappendix 3 - Directory Of Dermatology Deals By Stage Of Development 2007-2012appendix 4 – Directory Of Dermatology Deals By Technology Type 2007appendix 5 – Deal Type Definitionsabout Wildwood Venturescurrent Partneringcurrent Agreementsrecent Titles From Currentpartneringorder Form – ReportsAbout Us:Transparency Market Research is a market intelligence company providing global business informationreports and services. Our exclusive blend of quantitative forecasting and trends analysis providesforward-looking insight for thousands of decision makers. We are privileged with highly experienced team ofAnalysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques togather, and analyze information. Our business offerings represent the latest and the most reliable informationindispensable for businesses to sustain a competitive edge.Contact:ResearchMoz90 State Street,Suite 700,Albany NY - 12207United StatesTel: +1-518-618-1030USA - Canada Toll Free 866-997-4948Email: sales@researchmoz.usBlog: Partnering Terms and Agreements